Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $178.84 | 12 | 79.2% |
| Education | $46.91 | 1 | 20.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $63.10 | 4 | $0 (2021) |
| ITI, Inc. | $46.91 | 1 | $0 (2021) |
| Eisai Inc. | $42.57 | 3 | $0 (2021) |
| Corium, LLC | $25.50 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $19.62 | 1 | $0 (2021) |
| ABBVIE INC. | $14.57 | 1 | $0 (2024) |
| Alkermes, Inc. | $13.48 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.40 | 2 | ABBVIE INC. ($14.57) |
| 2023 | $26.15 | 2 | Alkermes, Inc. ($13.48) |
| 2021 | $93.09 | 4 | ITI, Inc. ($46.91) |
| 2020 | $66.22 | 4 | Sunovion Pharmaceuticals Inc. ($38.55) |
| 2018 | $12.89 | 1 | Sunovion Pharmaceuticals Inc. ($12.89) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/31/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/13/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: CNS | ||||||
| 09/21/2021 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $46.91 | General |
| Category: PSYCHIATRY | ||||||
| 04/22/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: PSYCHIATRY | ||||||
| 02/10/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: CNS | ||||||
| 01/12/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.90 | General |
| Category: Neurology | ||||||
| 11/19/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: CNS | ||||||
| 11/17/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.98 | General |
| Category: Neurology | ||||||
| 10/15/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.69 | General |
| Category: Neurology | ||||||
| 04/28/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: CNS | ||||||
| 02/05/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 167 | 509 | $74,680 | $26,033 |
| 2022 | 4 | 228 | 758 | $74,885 | $39,000 |
| 2021 | 4 | 263 | 925 | $93,200 | $53,792 |
| 2020 | 4 | 250 | 668 | $67,730 | $32,592 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 243 | $48,900 | $13,223 | 27.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 76 | 252 | $23,820 | $11,491 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $1,960 | $1,319 | 67.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 306 | $30,600 | $16,463 | 53.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 93 | 309 | $26,265 | $14,388 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 114 | $11,400 | $5,297 | 46.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 16 | 16 | $4,800 | $1,864 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $1,820 | $988.17 | 54.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 388 | $38,840 | $23,568 | 60.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 96 | 362 | $30,180 | $18,549 | 61.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 17 | 128 | $12,800 | $6,520 | 50.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 30 | 30 | $9,000 | $3,731 | 41.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 17 | $2,380 | $1,424 | 59.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 296 | $29,600 | $13,699 | 46.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 82 | 203 | $15,270 | $10,430 | 68.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 22 | 120 | $12,000 | $4,253 | 35.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 25 | 25 | $7,500 | $2,450 | 32.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 24 | $3,360 | $1,760 | 52.4% |
About Dr. John Hopper, MD
Dr. John Hopper, MD is a Psychiatry healthcare provider based in Rockport, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639155245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hopper, MD has received a total of $225.75 in payments from pharmaceutical and medical device companies, with $27.40 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($178.84).
As a Medicare-enrolled provider, Hopper has provided services to 908 Medicare beneficiaries, totaling 2,860 services with total Medicare billing of $151,417. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Rockport, TX
- Active Since 12/16/2005
- Last Updated 05/27/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639155245
Products in Payments
- LATUDA (Drug) $63.10
- CAPLYTA (Drug) $46.91
- Dayvigo (Drug) $42.57
- Azstarys (Drug) $25.50
- REXULTI (Drug) $19.62
- VRAYLAR (Drug) $14.57
- ARISTADA (Drug) $13.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Rockport
Dr. Kenneth Garcia, M.d, M.D
Psychiatry — Payments: $260.12
Dr. Robert Ruxin, Md, MD
Psychiatry — Payments: $117.38
Dr. Laurel Blackman, D.o., M.b.a, D.O., M.B.A
Psychiatry — Payments: $115.48
David Schmidt, M.d, M.D
Psychiatry — Payments: $20.49
David Bann, Md, MD
Psychiatry
Simon Eisen, M.d, M.D
Psychiatry